Book Text

REFERENCES

151. Schwartz AE, Matteo RS, Orstein E, et al: Pharmacokinetics of sufentanil in obese patients. Anesth Analg 73:790, 1991.

152. Weinstein JA, Matteo RS, Orstein E, et al: Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analg 67:1149, 1988.

153. Rosenbaum M, Leibel RL, Hirsch J: Obesity. N Engl J Med 337:396, 1997.

154. Sours HE, Frattali VP, Brand CD, et al: Sudden death associated with very low calorie weight reduction regimens. Am J Clin Nutr 34:453, 1981.

155. Warner MA, Warner ME, Martin JT: Ulnar neuropathy: Incidence, outcome, and risk factors in sedated and anesthetized patients. Anesthesiology 81:1332–1340, 1994.

156. Sawyer RJ, Richmond MN, Hickey JD, Jarratt JA: Peripheral nerve injuries associated with anaesthesia. Anaesthesia 55:980–991, 2000.

157. Goldbloom DS, Kennedy SH, Kaplan AS, et al: Anorexia nervosa and bulimia nervosa. Can Med Assoc J 140:1149, 1989.

158. Donini LM, Savina C, Cannella C: Eating habits and appetite control in the elderly: The anorexia of aging. Int Psychogeriatr 15:73–87, 2003.

159. Arnold DE, Rose RJ, Stoddard P: Intraoperative cardiac dysrhythmias in a patient with bulimic anorexia nervosa. Anesthesiology 67:1003, 1987.

160. Veterans Administration Total Parenteral Nutrition Cooperative Study Group: Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325:525, 1991.

161. Nicholas JM, Cornelius MW, Tchorz KM, et al: A two institution experience with 226 endoscopically placed jejunal feeding tubes in critically ill surgical patients. Am J Surg 186:583–590, 2003.

162. Starker PM, La Sala PA, Askanazi J, et al: The responses to TPN, a form of nutritional assessment. Ann Surg 198:720, 1983.

163. Lampe GH, Roizen MF: Anesthesia for patients with abnormal function of the adrenal cortex. Anesthesiol Clin North Am 5:245, 1987.

164. Hanowell ST, Hittner KC, Kim YD, et al: Anesthetic management of primary aldosteronism. Anesthesiol Rev 9:36, 1982.

165. Rabinowitz IN, Watson W, Farber EM: Topical steroid depression of the hypothalamic-pituitary-adrenal axis in psoriasis vulgaris. Dermatologica 154:321, 1977.

166. Knudsen L, Christiansen LA, Lorentzen JE: Hypotension during and after operation in glucocorticoid-treated patients. Br J Anaesth 53:295, 1981.

167. Cassinello Ogea C, Giron Nombiela JA, Ruiz Tramazaygues J, et al: Severe perioperative hypotension after nephrectomy with adrenalectomy [in Spanish]. Rev Esp Anestesiol Reanim 49:213–217, 2002.

168. Pleym H, Spigset O, Kharasch ED, Dale O: Gender differences in drug effects: Implications for anesthesiologists. Acta Anaesth Scand 47:241–259, 2003.

169. Symreng T, Karlberg BE, Kågedal B, et al: Physiological cortisol substitution of long-term steroid-treated patients undergoing major surgery. Br J Anaesth 53:949, 1981.

170. Udelsman R, Ramp J, Gallucci WT, et al: Adaptation during surgical stress: A reevaluation of the role of glucocorticoids. J Clin Invest 77:1377, 1986.

171. Axelrod L: Glucocorticoid therapy. Medicine (Baltimore) 55:39, 1976.

172. Graber AL, Ney RI, Nicholson WE, et al: Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab 25:11, 1965.

173. Ackerman GL, Nolsn CM: Adrenocortical responsiveness after alternate-day corticosteroid therapy. N Engl J Med 278:405–409, 1968.

174. Streck WF, Lockwood DH: Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med 66:910, 1979.

175. Cook DM, Loriaux DL: The incidental adrenal mass. Am J Med 101:88, 1996.

176. Linos DA, Stylopoulos N, Raptis SA: Adrenaloma: A call for more aggressive management. World J Surg 20:788, 1996.

177. Mantero F, Masini AM, Opocher G, et al: Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group. Horm Res 47:284, 1997.

178. Cook DM: Adrenal mass. Endocrinol Metab Clin North Am 26:829–852, 1997.

179. Volk T, Schmutzler M, Engelhardt L, et al: Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Acta Anaesthesiol Scand 47:667–674, 2003.

180. Derksen J, Negesser SK, Meinders AE, et al: Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 331:968–973, 1994.

181. Hollenberg NK, Williams GH: Hypertension, the adrenal and the kidney: Lessons from pharmacologic interruption of the renin-angiotensin system. Adv Intern Med 25:327, 1980.

182. Tyrrell JB, Brooks RM, Fitzgerald PA, et al: Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas. N Engl J Med 298:753–758, 1978.

183. Dale DC, Fauci AS, Wolff SM: Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. N Engl J Med 291:1154, 1974.

1132

184. Ehrlich HP, Hunt TK: Effects of cortisone and vitamin A on wound healing. Ann Surg 167:324–328, 1968.

185. Young WF Jr: Pheochromocytoma and primary hyperaldosteronism: Diagnostic approaches. Metab Clin North Am 26:801–827, 1997.

186. Jasani BM, Edmonds CJ: Kinetics of potassium distribution in man using isotope dilution and whole-body counting. Metabolism 20:1099, 1971.

187. Johnson JE, Hartsuck JM, Zollinger RM Jr, et al: Radiopotassium equilibrium in total body potassium: Studies using ⁴³ K and ⁴² K. Metabolism 18:663, 1969.

188. Surawicz B, Chlebus H, Mazzoleni A: Hemodynamic and electrocardiographic effects of hyperpotassemia: Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J 73:647, 1967.

189. Rao TLK, Jacobs KH, El-Etr AA: Reinfarction following anesthesia in patients with myocardial infarction. Anesthesiology 59:499, 1983.

190. Oh SH, Patterson R: Surgery in corticosteroid-dependent asthmatics. J Allergy Clin Immunol 53:345–351, 1974.

191. Schambelan M, Sebastian A: Hyporeninemic hypoaldosteronism. Adv Intern Med 24:385, 1979.

192. Oyama T, Taniguchi K, Jin T, et al: Effects of anaesthesia and surgery on plasma aldosterone concentration and renin activity in man. Br J Anaesth 51:747, 1979.

193. Nieman LK, Oldfield EH, Wesley R, et al: A simplified morning corticotrophin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome. J Clin Endocrinol Metab 77:1308, 1993.

194. Winstone NE, Brooke BN: Effects of steroid treatment on patients undergoing operation. Lancet 1:973, 1961.

195. Migeon C, Keller A, Lawrence B, Shepard T: DHA and androsterone levels in human plasma. Effect of age and sex: Day-to-day and diurnal variations. J Clin Endocrinol Metab 17:1051, 1957.

196. Wagner RL, White PF, Kan PB, et al: Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 310:1415, 1984.

197. Zurick AM, Sigurdsson H, Koehler LS, et al: Magnitude and time course of perioperative adrenal suppression with single dose etomidate in male adult cardiac surgical patients [abstract]. Anesthesiology 65:A248, 1986.

198. Gagner M, Breton G, Pharand D, Pomp A: Is laparoscopic adrenalectomy indicated for pheochromocytomas? Surgery 120:1076, 1996.

199. Linos DA, Stylopoulos N, Boukis M, et al: Anterior, posterior, or laparoscopic approach for the management of adrenal diseases? Am J Surg 173:120, 1997.

200. Bravo EL: Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev 15:356, 1994.

201. St John Sutton MG, Sheps SG, Lie JT: Prevalence of clinically unsuspected pheochromocytoma: Review of a 50-year autopsy series. Mayo Clin Proc 56:354, 1981.

202. Brown IE, Milshteyn M, Kleinman B, et al: Case 3-2002 pheochromocytoma presenting as a right intra-atrial mass. J Cardiothorac Vasc Anesth 16:370–373, 2002.

203. Witteles RM, Kaplan EL, Roizen MF: Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med 160:2521–2524, 2000.

204. Pauker SG, Kopelman RI: Interpreting hoofbeats: Can Bayes help clear the haze? N Engl J Med 327:1009, 1992.

205. Lucon AM, Pereira MAA, Mendonça BB, et al: Pheochromocytoma: Study of 50 cases. J Urol 157:1208, 1997.

206. Desmonts JM, le Houelleur J, Remond P, et al: Anaesthetic management of patients with pheochromocytoma: A review of 102 cases. Br J Anaesth 49:991, 1977.

207. Roizen MF, Horrigan RW, Koike M, et al: A prospective randomized trial of four anesthetic techniques for resection of pheochromocytoma [abstract]. Anesthesiology 57:A43, 1982.

208. Roizen MF, Hunt TK, Beaupre PN, et al: The effect of alpha-adrenergic blockade on cardiac performance and tissue oxygen delivery during excision of pheochromocytoma. Surgery 94:941, 1983.

209. Witteles RM, Kaplan EL, Roizen MF: Safe and cost-effective pheoperative preparation of patients with pheochromocytoma. Anesth Analg 91:302–304, 2000.

210. Allen GC, Rosenberg H: Pheochromocytoma presenting as acute malignant hyperthermia—a diagnostic challenge. Can J Anaesth 37:593, 1990.

211. Zakowski M, Kaufman B, Berguson P, et al: Esmolol use during resection of pheochromocytoma: Report of three cases. Anesthesiology 70:875, 1989.

212. Roizen MF, Schreider BD, Hassan SZ: Anesthetic for patients with pheochromocytoma. Anesthesiol Clin North Am 5:269, 1987.

213. Goldstein DS, Holmes C, Cannon RO III, et al: Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336:696, 1997.

214. Ziegler MG, Lake CR, Kopin IJ: The sympathetic nervous system defect in primary orthostatic hypotension. N Engl J Med 296:293, 1977.

215. Naftchi NE, Wooten GF, Lowman EW, et al: Relationship between serum dopamine-β-hydroxylase activity, catecholamine metabolism, and hemodynamic changes during paroxysmal hypertension in quadriplegia. Circ Res 35:850, 1974.

216. Cohen CA: Anesthetic management of a patient with the Shy-Drager syndrome. Anesthesiology 35:95, 1971.

217. McCaughey TJ: Familial dysautonomia as an anaesthetic hazard. Can J Anaesth 12:558, 1965.

218. Meridy HW, Creighton RE: General anaesthesia in eight patients with familial dysautonomia. Can J Anaesth 18:563, 1971.

219. Stowe DF, Bernstein JS, Madsen KE, et al: Autonomic hyperreflexia in spinal cord injured patients during extracorporeal shock wave lithotripsy. Anesth Analg 68:788, 1989.

220. Gronert GA, Theye RA: Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 43:89, 1975.

221. Jousse AT, Wynne-Jones M, Breithaupt DJ: A follow-up study of life expectancy and mortality in traumatic transverse myelitis. Can Med Assoc J 98:770, 1968.

222. Bevan DR: Shy-Drager syndrome. A review and a description of the anaesthetic management. Anaesthesia 34:866, 1979.

223. Malan MD, Crago RR: Anaesthetic considerations in idiopathic orthostatic hypotension and the Shy-Drager syndrome. Can J Anaesth 26:322, 1979.

224. Roizen MF: Should we all have a sympathectomy at birth? Or at least preoperatively? Anesthesiology 68:482, 1988.

225. Stone JG, Foëx P, Sear JW, et al: Myocardial ischemia in untreated hypertensive patients. Effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 68:495, 1988.

226. Mangano DT, Layug EL, Wallace A, et al: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335:1713, 1996.

227. Flacke JW, Bloor BC, Flacke WE, et al: Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology 67:11, 1987.

228. Ghignone M, Calvillo O, Quintin L: Anesthesia and hypertension: The effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology 67:3, 1987.

229. Yeager MP, Glass DD, Neff RK, Brinck-Johnsen T: Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology 66:729, 1987.

230. Roizen MF, Lampe GH, Benefiel DJ, et al: Is increased operative stress associated with worse outcome [abstract]. Anesthesiology 67:A1, 1987.

231. Fleisher LA, Rosenbaum SH, Nelson AH, Barash PG: The predictive value of preoperative silent ischemia for postoperative ischemic cardiac events in vascular and nonvascular surgery patients. Am Heart J 122:980, 1991.

232. Tuman KJ, McCarthy RJ, Spiess BD, et al: Effect of pulmonary artery catheterization on outcome in patients undergoing coronary artery surgery. Anesthesiology 70:199, 1989.

1133

233. Anand KJS, Hickey PR: Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. JAMA 326:1, 1992.

234. Bland JHL, Lowenstein E: Halothane-induced decrease in experimental myocardial ischemia in the non-failing canine heart. Anesthesiology 45:287, 1976.

235. Klassen GA, Bramwell RS, Bromage PR, Zborowska-Sluis DT: Effect of acute sympathectomy by epidural anesthesia on the canine coronary circulation. Anesthesiology 52:8, 1980.

236. Norris RM, Clarke ED, Sammel NL, et al: Protective effect of propranolol in threatened myocardial infarction. Lancet 2:907, 1978.

237. Levine JD, Dardick SJ, Roizen MF, et al: The contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 6:3423, 1986.

238. Feigl EO: The paradox of adrenergic coronary vasoconstriction. Circulation 76:737, 1987.

239. Wade JG, Larson CP, Hickey RF, et al: Carotid endarterectomy and carotid chemoreceptor and baroreceptor function in man. N Engl J Med 282:823, 1970.

240. Hui KKP, Conolly ME: Increased numbers of beta receptors in orthostatic hypotension due to autonomic dysfunction. N Engl J Med 304:1473, 1981.

241. Kendrick WW, Scott JW, Jousse AT, et al: Reflex sweating and hypertension in traumatic transverse myelitis. Treat Serv Bull (Ottawa) 8:437, 1953.

242. Woeber KA: Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med 160:1067–1071, 2000.

243. Amino N, Mori H, Iwatani Y, et al: High prevalence of transient postpartum thyrotoxicosis and hypothyroidism. N Engl J Med 306:849, 1982.

244. Farling PA. Thyroid disease. Br J Anaesth 85:15–28, 2000.

245. Channick BJ, Adlin EV, Marks AD, et al: Hyperthyroidism and mitral-valve prolapse. N Engl J Med 305:497, 1981.

246. Forfar JC, Miller HC, Toft AD: Occult thyrotoxicosis: A correctable cause of "idiopathic" atrial fibrillation. Am J Cardiol 44:9, 1979.

247. Feek CM, Sawers JSA, Irvine WJ, et al: Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. N Engl J Med 302:883, 1980.

248. Forfar JC, Muir AL, Sawers SA, Toft AD: Abnormal left ventricular function in hyperthyroidism: Evidence for a possible reversible cardiomyopathy. N Engl J Med 307:1165, 1982.

249. Tenerz Å, Forberg R, Jansson R: Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med 228:229, 1990.

250. Eriksson M, Rubenfeld S, Garber AJ, et al: Propranolol does not prevent thyroid storm. N Engl J Med 296:263, 1977.

251. Roizen MF, Becker CE: Thyroid storm: A review of cases at University of California, San Francisco. Calif Med 115:5, 1971.

252. Loh KC: Amiodarone-induced thyroid disorders: A clinical review. Postgrad Med J 76:133–140, 2000.

253. Williams M, Lo Gerfo P: Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: A review and description of the technique. Thyroid 12:523–525, 2002.

254. Murkin JM: Anesthesia and hypothyroidism: A review of thyroxine physiology, pharmacology, and anesthetic implications. Anesth Analg 61:371, 1982.

255. Sawin CT, Castelli WP, Hershman JM, et al: The aging thyroid: Thyroid deficiency in the Framingham Study. Arch Intern Med 145:1386, 1985.

256. Weinberg AD, Brennan MD, Gorman CA, et al: Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med 143:893, 1983.

257. Vanderpump MPJ, Tunbridge WMG, French JM, et al: The incidence of thyroid disorders in the community: A twenty-year follow-up of the Wickham Survey. Clin Endocrinol 43:55, 1995.

258. Zwillich CW, Pierson DJ, Hofeldt FD, et al: Ventilatory control in myxedema and hypothyroidism. N Engl J Med 292:662, 1975.

259. Hattori H, Hattori C, Yonekura A, Nishimura T: Two cases of sleep apnea syndrome caused by primary hypothyroidism. Acta Otolaryngol Suppl 550:59–64, 2003.

260. Bough EW, Crowley WF, Ridgway EC, et al: Myocardial function in hypothyroidism. Relation to disease severity and response to treatment. Arch Intern Med 138:1476, 1978.

261. Babad AA, Eger EI II: The effects of hyperthyroidism and hypothyroidism on halothane and oxygen requirements in dogs. Anesthesiology 29:1087, 1968.

262. Karga HJ, Papapetrou PD, Karpathios SE, et al: L-thyroxine therapy attenuates the decline in serum triiodothyronine in nonthyroidal illness induced by hysterectomy. Metabolism 52:1307–1312, 2003.

263. Levine HD: Compromise therapy in the patient with angina pectoris and hypothyroidism: A clinical assessment. Am J Med 69:411, 1980.

264. McMurphy RM, Hodgson DS, Bruyette DS, Fingland RB: Cardiovascular effects of 1.0, 1.5, and 2.0 minimum alveolar concentrations of isoflurane in experimentally induced hypothyroidism in dogs. Vet Surg 25:171–178, 1996.

265. Hensel P, Roizen MF: Patients with disorders of parathyroid function. Anesthesiol Clin North Am 5:287, 1987.

266. Lind L, Ljunghall S: Blood pressure reaction during the intraoperative and early postoperative periods in patients with primary hyperparathyroidism. Expl Clin Endocrinol 102:409–413, 1994.

267. Gallagher SF, Denham DW, Murr MM, Norman JG: The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism. Surgery 134:910–917, 2000.

268. Kebebew E, Duh QY, Clark OH: Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: A plea for early surgical referral. Arch Surg 138:867–871, 2003.

269. Mihai R, Farndon JR: Parathyroid disease and calcium metabolism. Br J Anaesth 85:29–43, 2000.

270. Kao PC, van Heerden JA, Taylor RL: Intraoperative monitoring of parathyroid procedures by a 15-minute parathyroid hormone immunochemiluminometric assay. Mayo Clin Proc 69:532, 1994.

271. Lang RM, Fellner SK, Neumann A, et al: Left ventricular contractility varies directly with blood ionized calcium. Ann Intern Med 108:524, 1988.

272. Rumancik WM, Denlinger JK, Nahrwold ML, et al: The QT interval and serum ionized calcium. JAMA 240:366, 1978.

273. Munir MA, Jaffar M, Arshad M, et al: Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient. Can J Anaesth 50:558–561, 2003.

274. Melmed S, Ho K, Klibanski A, et al: Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 80:3395, 1995.

275. Schmitt H, Buchfelder M, Radespiel-Troger M, Fahlbusch R: Difficult intubation in acromegalic patients: Incidence and predictability. Anesthesiology 93:110–114, 2000.

276. Dougherty TB, Cronau LH Jr: Anesthetic implications for surgical patients with endocrine tumors. Int Anesthesiol Clin 36:31–44, 1998.

277. Campkin TV: Radial artery cannulation: Potential hazard in patients with acromegaly. Anaesthesia 35:1008, 1980.

278. Molitch EM: Diagnosis and treatment of prolactinomas. Adv Intern Med 44:117–153, 1999.

279. Rojiani AM, Prineas JW, Cho ES: Protective effect of steroids on electrolyte-induced demyelination. J Neuropathol Exp Neurol 46:495, 1987.

280. Ayus JC, Krothapalli RK, Arieff AI: Changing concepts in the treatment of severe symptomatic hyponatremia: Rapid correction and possible relation to central pontine myelinolysis. Am J Med 78:897, 1985.

281. Robertson GL: Diabetes insipidus. Endocrinol Metab Clin North Am 24:549, 1995.

1134

282. Corliss RJ, McKenna DH, Sialers S, et al: Systemic and coronary hemodynamic effects of vasopressin. Am J Med Sci 256:293, 1968.

283. Nikolic G, Singh JB: Cimetidine, vasopressin and chronotropic incompetence. Med J Aust 2:435, 1982.

284. Smithwick RH, Thompson JE: Splanchnicectomy for essential hypertension. JAMA 152:1501, 1953.

285. Brown BR: Anesthesia and essential hypertension. In Hershey SG (ed): ASA Refresher Courses in Anesthesiology, vol 7. Philadelphia, JB Lippincott, 1979, p 41.

286. Sprague HB: The heart in surgery. An analysis of results of surgery on cardiac patients during the past ten years at the Massachusetts General Hospital. Surg Gynecol Obstet 49:54, 1929.

287. Miller RD, Way WL, Eger EI II: The effects of alpha-methyldopa, reserpine, and guanethidine on minimum alveolar anesthetic requirement (MAC). Anesthesiology 29:1153, 1968.

288. Veterans Administration Study on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. JAMA 202:1028, 1967.

289. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213:1143, 1970.

290. Moser M, Hebert P, Hennekens CH: An overview of the meta-analyses of the hypertension treatment trials. Arch Intern Med 151:1277, 1991.

291. Kannel WB: Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA 275:1571, 1996.

292. Hypertension Detection and Follow-up Program Cooperative Group: The effect of treatment on mortality in "mild" hypertension. N Engl J Med 307:976, 1982.

293. Multiple Risk Factor Intervention Trial Research Group: Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 248:1465, 1982.

294. Psaty BM, Smith NL, Siscovick DS, et al: Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 277:739–745, 1997.

295. Heidenreich PA, McDonald KM, Hastie T: Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 281:1927–1936, 1999.

296. Jollis, JG, Simpson RJ Jr, Chowdhury MK, et al: Calcium channel blockers and mortality in elderly patients with myocardial infarction. Arch Intern Med 159:2341–2348, 1999.

297. Opie, LH, Yusuf S, Kubler W: Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies. Prog Cardiovasc Dis 43:171–196, 2000.

298. SHEP Cooperative Study Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265:3255, 1991.

299. Curb JD, Pressel SL, Cutler JA, et al: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276:1886, 1996.

300. Farnett L, Mulrow CD, Linn WD, et al: The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 265:489, 1991.